Gotowa bibliografia na temat „Potentiators”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Potentiators”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Potentiators"
Cui, Guiying, i Nael A. McCarty. "Murine and human CFTR exhibit different sensitivities to CFTR potentiators". American Journal of Physiology-Lung Cellular and Molecular Physiology 309, nr 7 (1.10.2015): L687—L699. http://dx.doi.org/10.1152/ajplung.00181.2015.
Pełny tekst źródłaFowler, Jill H., Katherine Whalley, Tracey Murray, Michael J. O'Neill i James McCulloch. "The AMPA Receptor Potentiator LY404187 Increases Cerebral Glucose Utilization and c-fos Expression in the Rat". Journal of Cerebral Blood Flow & Metabolism 24, nr 10 (październik 2004): 1098–109. http://dx.doi.org/10.1097/01.wcb.0000138665.25305.7c.
Pełny tekst źródłaRighetti, Giada, Monica Casale, Michele Tonelli, Nara Liessi, Paola Fossa, Nicoletta Pedemonte, Enrico Millo i Elena Cichero. "New Insights into the Binding Features of F508del CFTR Potentiators: A Molecular Docking, Pharmacophore Mapping and QSAR Analysis Approach". Pharmaceuticals 13, nr 12 (4.12.2020): 445. http://dx.doi.org/10.3390/ph13120445.
Pełny tekst źródłaFavia, Maria, Maria T. Mancini, Valentino Bezzerri, Lorenzo Guerra, Onofrio Laselva, Anna C. Abbattiscianni, Lucantonio Debellis i in. "Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 307, nr 1 (1.07.2014): L48—L61. http://dx.doi.org/10.1152/ajplung.00305.2013.
Pełny tekst źródłaBacalhau, Mafalda, Filipa C. Ferreira, Iris A. L. Silva, Camilla D. Buarque, Margarida D. Amaral i Miquéias Lopes-Pacheco. "Additive Potentiation of R334W-CFTR Function by Novel Small Molecules". Journal of Personalized Medicine 13, nr 1 (1.01.2023): 102. http://dx.doi.org/10.3390/jpm13010102.
Pełny tekst źródłaPedemonte, Nicoletta, Valeria Tomati, Elvira Sondo i Luis J. V. Galietta. "Influence of cell background on pharmacological rescue of mutant CFTR". American Journal of Physiology-Cell Physiology 298, nr 4 (kwiecień 2010): C866—C874. http://dx.doi.org/10.1152/ajpcell.00404.2009.
Pełny tekst źródłaMancini, Giulia, Nicoletta Loberto, Debora Olioso, Maria Cristina Dechecchi, Giulio Cabrini, Laura Mauri, Rosaria Bassi i in. "GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease". International Journal of Molecular Sciences 21, nr 12 (24.06.2020): 4486. http://dx.doi.org/10.3390/ijms21124486.
Pełny tekst źródłaBasta, Karol, i Chris John. "Combination Correctors and Potentiators for Cystic Fibrosis". Physician 6, nr 1 (27.11.2019): c7. http://dx.doi.org/10.38192/1.6.1.c7.
Pełny tekst źródłaCuyx, Senne, i Kris De Boeck. "Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis". Seminars in Respiratory and Critical Care Medicine 40, nr 06 (28.10.2019): 762–74. http://dx.doi.org/10.1055/s-0039-1696664.
Pełny tekst źródłaMareux, Elodie, Martine Lapalus, Amel Ben Saad, Renaud Zelli, Mounia Lakli, Yosra Riahi, Marion Almes i in. "In Vitro Rescue of the Bile Acid Transport Function of ABCB11 Variants by CFTR Potentiators". International Journal of Molecular Sciences 23, nr 18 (15.09.2022): 10758. http://dx.doi.org/10.3390/ijms231810758.
Pełny tekst źródłaRozprawy doktorskie na temat "Potentiators"
Voss, Oliver Paul. "AMPA receptor potentiators : mechanisms of neuroplasticity". Thesis, University of Edinburgh, 2007. http://hdl.handle.net/1842/25276.
Pełny tekst źródłaKrishnan, Ramya. "Characterization of Novel Small Molecule Potentiators of Oncolytic Virotherapy". Thesis, Université d'Ottawa / University of Ottawa, 2018. http://hdl.handle.net/10393/37551.
Pełny tekst źródłaEl-Sayes, Nader. "Small Molecule Potentiators of Oncolytic Virus Therapy Suppress the Innate Antiviral Response". Thesis, Université d'Ottawa / University of Ottawa, 2018. http://hdl.handle.net/10393/37115.
Pełny tekst źródłaKinting, Susanna [Verfasser], i Heinrich [Akademischer Betreuer] Leonhardt. "Functional rescue of mutant ABCA3 by correctors and potentiators / Susanna Kinting ; Betreuer: Heinrich Leonhardt". München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2019. http://d-nb.info/1204005281/34.
Pełny tekst źródłaQuintela, Varela Hugo [Verfasser], i Dirk [Akademischer Betreuer] Trauner. "Biomimetic synthesis of (−)-PF-1018 and development of photoswitchable GABAA receptor potentiators / Hugo Quintela Varela ; Betreuer: Dirk Trauner". München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2019. http://d-nb.info/1221960458/34.
Pełny tekst źródłaMareux, Elodie. "Pharmacothérapie ciblée des déficits en ABCB11". Electronic Thesis or Diss., université Paris-Saclay, 2021. http://www.theses.fr/2021UPASL083.
Pełny tekst źródłaABCB11/BSEP (Bile Salt Export Pump) is expressed at the canalicular membrane of hepatocytes. It ensures bile acids secretion into bile which is essential for biliary secretion. Nearly 400 variations of the ABCB11 gene have been identified and are associated with rare hepatobiliary diseases, the most severe being progressive familial intrahepatic cholestasis type 2 (PFIC2). The effectiveness of medical treatments is limited. Consequently, liver transplantation is required before adulthood for almost 2/3 of PFIC2 patients. In this context, the identification of alternative therapies is a major challenge.This thesis focuses on personalized therapeutic strategies to correct the pathological consequences of some ABCB11 variations identified in patients. The A257V, G562D and T463I variations of ABCB11 were studied by 3D molecular modelling. These variations were responsible for a defect in Abcb11 transport function. Ivacaftor (VX-770, Kalydeco®), a clinically approved cystic fibrosis treatment, corrects the activity defect of the three variants.Similar effects were observed with GLPG1837, SBC040 and SBC219, known as potentiators of CFTR (Cystic Fibrosis Transmembrane Conductance Regulator).From a combinatory therapy perspective, we also demonstrated the ability of these potentiators to correct the transport defect of the R1090C and R1090W variants, potential readthrough products of the R1090X nonsense variant. We also evaluated the ability of Elexacaftor (VX-445) and Tezacaftor (VX 661) correctors of CFTR. These correctors, alone or in combination, restored trafficking of the R1128C missense variant, leading to a significant increase in the transport function. Interestingly, the addition of potentiators abolishes this effect.Altogether, this thesis constitutes a proof of concept that molecules with high therapeutic potential can correct the molecular defects of ABCB11 variants. These treatments could increase the pharmacopoeia available for patients with ABCB11 deficiency and thus delay or even suppress the need for liver transplantation
Hanoteau, Aurélie. "Chemotherapy potentiates immune responses against murine tumors". Doctoral thesis, Universite Libre de Bruxelles, 2016. https://dipot.ulb.ac.be/dspace/bitstream/2013/231745/5/Thesis.pdf.
Pełny tekst źródłaOption Biologie moléculaire du Doctorat en Sciences
info:eu-repo/semantics/nonPublished
Khalil, Dayekh. "Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity". Thèse, Université d'Ottawa / University of Ottawa, 2013. http://hdl.handle.net/10393/24405.
Pełny tekst źródłaLortie, Karine. "The growth-arrest-specific protein gas7 potentiates neuronal differentiation". Thesis, University of Ottawa (Canada), 2004. http://hdl.handle.net/10393/26701.
Pełny tekst źródłaSeufert, Florian [Verfasser], i Ulrike [Gutachter] Holzgrabe. "Entwicklung von Inhibitoren des „macrophage infectivity potentiator“-Proteins / Florian Seufert. Gutachter: Ulrike Holzgrabe". Würzburg : Universität Würzburg, 2016. http://d-nb.info/1112041222/34.
Pełny tekst źródłaKsiążki na temat "Potentiators"
Singh, Manmohan, red. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Boston, MA: Springer US, 2013. http://dx.doi.org/10.1007/978-1-4614-5380-2.
Pełny tekst źródłaDare, Amos O. Ouabain potentiates kainate neurotoxicity: A new rat model of human temporal lobe epilepsy. [New Haven, Conn: s.n.], 1996.
Znajdź pełny tekst źródłaSchwartz, Gary K. Combination Cancer Therapy: Modulators and Potentiators. Humana Press, 2014.
Znajdź pełny tekst źródłaSchwartz, Gary K. Combination Cancer Therapy: Modulators and Potentiators. Humana Press, 2004.
Znajdź pełny tekst źródłaSingh, Manmohan. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Springer London, Limited, 2013.
Znajdź pełny tekst źródłaSingh, Manmohan. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Springer, 2015.
Znajdź pełny tekst źródłaNovel Immune Potentiators And Delivery Technologies For Next Generation Vaccines. Springer-Verlag New York Inc., 2012.
Znajdź pełny tekst źródłaCombination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development). Humana Press, 2004.
Znajdź pełny tekst źródłaThe New Superantioxidant-Plus : The Amazing Story of Pycnogenol, Free-Radical Antagonist and Vitamin C Potentiator (Good Health Guide Series). McGraw-Hill, 1998.
Znajdź pełny tekst źródłaMain, Jeffrey Scott *. Heart failure potentiates the modulatory influence of the endothelium on alpha-adrenergic-mediated responses in canine coronary arteries. 1989.
Znajdź pełny tekst źródłaCzęści książek na temat "Potentiators"
Heath, Henry B., i Gary Reineccius. "Flavor Potentiators". W Flavor Chemistry and Technology, 318–31. London: Macmillan Education UK, 1986. http://dx.doi.org/10.1007/978-1-349-09350-2_9.
Pełny tekst źródłaHeath, Henry B., i Gary Reineccius. "Flavor Potentiators". W Flavor Chemistry and Technology, 318–31. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-011-9759-5_9.
Pełny tekst źródłaLindenmann, J. "The Use of Viruses as Immunological Potentiators". W Ciba Foundation Symposium 18 - Immunopotentiation, 197–215. Chichester, UK: John Wiley & Sons, Ltd., 2008. http://dx.doi.org/10.1002/9780470720011.ch10.
Pełny tekst źródłaShikina, Shinya, i Ching-Fong Chang. "Neuropeptides as Potentiators of Coral Polyp Contraction". W Frontiers in Invertebrate Physiology: A Collection of Reviews, 317–41. New York: Apple Academic Press, 2023. http://dx.doi.org/10.1201/9781003403319-6.
Pełny tekst źródłaGarro-Martínez, Emilio, i Albert Adell. "AMPA Receptor Potentiators as Potential Rapid-Acting Antidepressants". W Contemporary Clinical Neuroscience, 85–109. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-79790-4_6.
Pełny tekst źródłaTomai, Mark A., i John P. Vasilakos. "TLR7/8 Agonists as Vaccine Adjuvants". W Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines, 3–18. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-5380-2_1.
Pełny tekst źródłaAndrianov, Alexander K. "Microneedles for Intradermal Vaccination: Immunopotentiation and Formulation Aspects". W Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines, 217–32. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-5380-2_10.
Pełny tekst źródłaSingh, Parminder, Guohua Chen i Wade Worsham. "MicroCor® Transdermal Delivery System: A Safe, Efficient, and Convenient Transdermal System for Vaccine Administration". W Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines, 233–44. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-5380-2_11.
Pełny tekst źródłaLeenhouts, Kees. "Mimopath™-Based Vaccine Delivery". W Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines, 245–65. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-5380-2_12.
Pełny tekst źródłaHamouda, Tarek, Jakub Simon, Ali Fattom i James Baker. "NanoBio™ Nanoemulsion for Mucosal Vaccine Delivery". W Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines, 269–86. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-5380-2_13.
Pełny tekst źródłaStreszczenia konferencji na temat "Potentiators"
Prasetyoputri, Anggia, Mega Ferdina Warsito, Akhirta Atikana, Eko Wahyu Putro, Lutfi Nia Kholida i Linda Sukmarini. "Antibiotic potentiators to combat resistance in methicillin-resistant Staphylococcus aureus (MRSA): A mini review". W PROCEEDINGS OF THE 9TH INTERNATIONAL SYMPOSIUM ON INNOVATIVE BIOPRODUCTION INDONESIA ON BIOTECHNOLOGY AND BIOENGINEERING 2022: Strengthening Bioeconomy through Applied Biotechnology, Bioengineering, and Biodiversity. AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0185419.
Pełny tekst źródłaHeneghan, M., KW Southern, J. Murphy, IP Sinha i SJ Nevitt. "P70 Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)". W British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and Abstracts. BMJ Publishing Group Ltd and British Thoracic Society, 2022. http://dx.doi.org/10.1136/thorax-2022-btsabstracts.206.
Pełny tekst źródłaGrosche, A., X. Xu, S. Lin, M. Abu-Hassan, S. Prabhakaran i S. Vidyasagar. "Amino Acids Regulate Defective CFTR Trafficking and Gating in Primary Human F508del-Bronchial Epithelial Cells Similar to Cystic Fibrosis Correctors and Potentiators". W American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7455.
Pełny tekst źródłaUluata, Sibel, Seymanur Avci i Gokhan Durmaz. "Comparing Physical Stability of Ultrasound and Pickering Emulsion Fortified with Vitamin D". W 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/cwoy2387.
Pełny tekst źródłaJoseph, S. K., S. Krishnamurthi i V. V. Kakkar. "R59022, A DIACYLGLYCEROL (DG) KINASE INHIBITOR POTENTIATES THROMBIN-INDUCED PLATELET AGGREGATION AND GRANULE RELEASE". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644504.
Pełny tekst źródłaSchaible, N., R. Guo, E. Phalen, K. Chmiel, X. Ai, Y. Bai, A. A. Zeki i R. Krishnan. "Pitavastatin Potentiates Beta2-Agonist Induced Bronchodilation". W American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5496.
Pełny tekst źródłaSherrill, Taylor P., George Stathopoulos, Fiona E. Yull, Barbara Fingleton i Timothy S. Blackwell. "Host-Derived Interleukin-5 Potentiates Lung Metastasis". W American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2522.
Pełny tekst źródłaTakada, Y., Y. Sugawara, Y. Makino i A. Takada. "KINETIC ANALYSES OF THE ACTIVATION OF GLU- OR LYS-PLASMINOGEN BY STREPTOKINASE IN THE PRESENCE OF FIBRIN OR ITS DEGRADATION PRODUCTS". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644419.
Pełny tekst źródłaHanthazi, Aliénor, Samantha Gomart, Caroline Gaudreau Ménard, Pascale Jespers, Jean-Yves Springael, Robert Naeije, Laurence Dewachter i Kathleen Mc Entee. "Chemerin potentiates pulmonary artery reactivity to endothelin-1". W Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2440.
Pełny tekst źródłaKurai, Jun, Rebecca L. Toonkel, Alain Borczuk i Charles A. Powell. "Oxidative Stress Potentiates Carcinogenesis In Chronic Lung Inflammation". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4953.
Pełny tekst źródłaRaporty organizacyjne na temat "Potentiators"
Fisher, Joshua L. Selenium Potentiates Chemotherapeutic Selectivity: Improving Efficacy and Reducing Toxicity. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2007. http://dx.doi.org/10.21236/ada470578.
Pełny tekst źródłaHuacani, Maria R., i D. McDonnell. Analysis of the Mechanism of Action of RPF1: Potentiator of Progesterone Receptor and p53-Dependent Transcriptional Activity. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2001. http://dx.doi.org/10.21236/ada398343.
Pełny tekst źródłaGreen, Lora M. Low Dose Gamma Irradiation Potentiates Secondary Exposure to Gamma Rays or Protons in Thyroid Tissue Analogs. Office of Scientific and Technical Information (OSTI), maj 2006. http://dx.doi.org/10.2172/882942.
Pełny tekst źródłaZlotkin, Eliahu, Shizuo G. Kamita, Nor Chejanovsky i S. Maeda. Targeting of an Expressed Insect Selective Neurotoxin by its Recombinant Baculovirus: Pharmacokinetic and Pharmacodynamic Aspects. United States Department of Agriculture, lipiec 1995. http://dx.doi.org/10.32747/1995.7571354.bard.
Pełny tekst źródłaYaron, Zvi, Martin P. Schreibman, Abigail Elizur i Yonathan Zohar. Advancing Puberty in the Black Carp (Mylopharyngodon Piceus) and the Striped Bass (Morone Saxatilis). United States Department of Agriculture, sierpień 1993. http://dx.doi.org/10.32747/1993.7568102.bard.
Pełny tekst źródła